Terms/Glossary

News & Events > 2010 Press releases

Skriv ut

2010 Press releases

20 December 2010
Clavis Pharma’s elacytarabine granted FDA Fast Track designation in USA

10 December 2010
Prospectus approved

9 December 2010
Clavis Pharma’s NOK 154 million Private Placement approved at Extraordinary General Meeting

1 December 2010
Clavis Pharma presented at the Nordic Health Care Conference 2010

19 November 2010
Registration to attend the Extraordinary General Meeting on 9 December 2010

18 November 2010
Clavis Pharma raises NOK 154 million (EUR 19 million) in a private placement

18 November 2010
Notice of Extraordinary General Meeting

11 November 2010
Invitation Meeting & Conference Call for Clavis Pharma's new $205 million deal with Clovis Oncology for the development & commercialisation of anti-cancer agent CP-4126 in Asia and Rest of the World

11 November 2010
Clavis Pharma and Clovis Oncology Extend Partnership and Sign New $205 Million Deal for the Development and Commercialisation of Anti-Cancer Agent CP-4126 in Asia and Rest of the World

21 October 2010
Clavis Pharma - Third Quarter Report 2010